Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 13 studies | 23% ± 9% | |
endothelial cell | 11 studies | 25% ± 10% | |
classical monocyte | 5 studies | 21% ± 4% | |
connective tissue cell | 5 studies | 21% ± 4% | |
pericyte | 5 studies | 23% ± 4% | |
epithelial cell | 5 studies | 33% ± 13% | |
natural killer cell | 5 studies | 18% ± 1% | |
retinal ganglion cell | 4 studies | 53% ± 29% | |
smooth muscle cell | 4 studies | 21% ± 5% | |
endothelial cell of lymphatic vessel | 4 studies | 23% ± 5% | |
pancreatic A cell | 3 studies | 27% ± 15% | |
non-classical monocyte | 3 studies | 28% ± 5% | |
myofibroblast cell | 3 studies | 20% ± 4% | |
amacrine cell | 3 studies | 30% ± 9% | |
ciliated cell | 3 studies | 21% ± 3% | |
abnormal cell | 3 studies | 22% ± 3% | |
endothelial cell of vascular tree | 3 studies | 19% ± 3% | |
type I pneumocyte | 3 studies | 24% ± 4% | |
CD8-positive, alpha-beta T cell | 3 studies | 18% ± 1% | |
basal cell | 3 studies | 28% ± 10% | |
plasmacytoid dendritic cell | 3 studies | 22% ± 2% | |
neuron | 3 studies | 35% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 6934.04 | 258 / 258 | 100% | 146.79 | 230 / 230 |
esophagus | 100% | 5753.17 | 1445 / 1445 | 100% | 67.91 | 183 / 183 |
kidney | 100% | 5228.87 | 89 / 89 | 100% | 110.79 | 901 / 901 |
liver | 100% | 4440.32 | 226 / 226 | 100% | 95.00 | 406 / 406 |
ovary | 100% | 7623.25 | 180 / 180 | 100% | 106.68 | 430 / 430 |
skin | 100% | 5799.87 | 1809 / 1809 | 100% | 129.25 | 472 / 472 |
stomach | 100% | 5028.97 | 359 / 359 | 100% | 79.46 | 286 / 286 |
thymus | 100% | 5528.39 | 653 / 653 | 100% | 112.45 | 605 / 605 |
brain | 100% | 5487.97 | 2638 / 2642 | 100% | 98.07 | 705 / 705 |
prostate | 100% | 6099.03 | 245 / 245 | 100% | 125.40 | 501 / 502 |
uterus | 100% | 6641.44 | 170 / 170 | 100% | 93.90 | 458 / 459 |
pancreas | 100% | 3420.16 | 327 / 328 | 100% | 101.78 | 178 / 178 |
lung | 100% | 4926.81 | 577 / 578 | 100% | 89.35 | 1153 / 1155 |
intestine | 100% | 6317.33 | 966 / 966 | 100% | 82.89 | 525 / 527 |
breast | 100% | 6065.06 | 459 / 459 | 99% | 115.96 | 1111 / 1118 |
bladder | 100% | 6501.14 | 21 / 21 | 99% | 103.61 | 500 / 504 |
adipose | 100% | 6382.94 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6215.58 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 119.49 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 72.53 | 29 / 29 |
spleen | 100% | 5019.13 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 72.54 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 77.94 | 1 / 1 |
heart | 100% | 4747.22 | 860 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 3365.53 | 920 / 929 | 0% | 0 | 0 / 0 |
muscle | 98% | 1996.86 | 783 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006661 | Biological process | phosphatidylinositol biosynthetic process |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0003881 | Molecular function | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | CDIPT |
Protein name | CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase) (PtdIns synthase) CDP-diacylglycerol--inositol 3-phosphatidyltransferase (cDNA FLJ16129 fis, clone BRACE2039823, highly similar to CDP-diacylglycerol--inositol3-phosphatidyltransferase) CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) CDP-diacylglycerol--inositol 3-phosphatidyltransferase |
Synonyms | PIS1 hCG_21626 PIS |
Description | FUNCTION: Catalyzes the biosynthesis of phosphatidylinositol (PtdIns) as well as PtdIns:inositol exchange reaction. May thus act to reduce an excessive cellular PtdIns content. The exchange activity is due to the reverse reaction of PtdIns synthase and is dependent on CMP, which is tightly bound to the enzyme. . |
Accessions | ENST00000561555.5 O14735 ENST00000564296.5 A8K3L7 ENST00000569956.5 [O14735-1] ENST00000570016.5 [O14735-1] B3KY94 H3BUR9 H3BTJ7 ENST00000566113.5 [O14735-3] ENST00000219789.11 [O14735-1] ENST00000563415.1 B3KSW0 |